| 000 | 01737 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250511180616.0 | ||
| 264 | 0 | _c19930121 | |
| 008 | 199301s 0 0 eng d | ||
| 022 | _a0261-4189 | ||
| 024 | 7 |
_a10.1002/j.1460-2075.1992.tb05588.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aNaldini, L | |
| 245 | 0 | 0 |
_aExtracellular proteolytic cleavage by urokinase is required for activation of hepatocyte growth factor/scatter factor. _h[electronic resource] |
| 260 |
_bThe EMBO journal _cDec 1992 |
||
| 300 |
_a4825-33 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aCells, Cultured |
| 650 | 0 | 4 | _aElectrophoresis, Polyacrylamide Gel |
| 650 | 0 | 4 |
_aExtracellular Matrix _xdrug effects |
| 650 | 0 | 4 |
_aHepatocyte Growth Factor _xmetabolism |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aHydrolysis |
| 650 | 0 | 4 | _aProtein Processing, Post-Translational |
| 650 | 0 | 4 |
_aProtein-Tyrosine Kinases _xmetabolism |
| 650 | 0 | 4 |
_aProto-Oncogene Proteins _xmetabolism |
| 650 | 0 | 4 | _aProto-Oncogene Proteins c-met |
| 650 | 0 | 4 |
_aReceptors, Cell Surface _xmetabolism |
| 650 | 0 | 4 |
_aSerine Proteinase Inhibitors _xpharmacology |
| 650 | 0 | 4 | _aTumor Cells, Cultured |
| 650 | 0 | 4 |
_aUrokinase-Type Plasminogen Activator _xantagonists & inhibitors |
| 700 | 1 | _aTamagnone, L | |
| 700 | 1 | _aVigna, E | |
| 700 | 1 | _aSachs, M | |
| 700 | 1 | _aHartmann, G | |
| 700 | 1 | _aBirchmeier, W | |
| 700 | 1 | _aDaikuhara, Y | |
| 700 | 1 | _aTsubouchi, H | |
| 700 | 1 | _aBlasi, F | |
| 700 | 1 | _aComoglio, P M | |
| 773 | 0 |
_tThe EMBO journal _gvol. 11 _gno. 13 _gp. 4825-33 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/j.1460-2075.1992.tb05588.x _zAvailable from publisher's website |
| 999 |
_c1340982 _d1340982 |
||